CIK 0001701541 · Non-accelerated filer<br>Smaller reporting company
Black Diamond Therapeutics, Inc.
Sign in to watch- Ticker
- BDTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 814254660
- Phone
- 617-417-5868
- Business address
- 245 FIRST STREET, 18TH FLOOR, CAMBRIDGE, MA, 02142
- Former names
- Aset Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-19 | BIOTECH GROWTH N V 10% owner | Sale | −1,000,000 | $2.07 | $2.1M | 7,517,839 |
| 2025-03-19 | BIOTECH GROWTH N V 10% owner | Sale | −300,000 | $1.94 | $583K | 7,217,839 |
| 2025-03-19 | BIOTECH GROWTH N V 10% owner | Sale | −1,000,000 | $2.31 | $2.3M | 6,217,839 |
| 2025-03-19 | BIOTECH GROWTH N V 10% owner | Sale | −2,000,000 | $2.00 | $4.0M | 4,217,839 |
| 2025-03-19 | BIOTECH GROWTH N V 10% owner | Sale | −400,000 | $2.09 | $837K | 3,817,839 |
| 2025-03-19 | BIOTECH GROWTH N V 10% owner | Sale | −584,292 | $1.95 | $1.1M | 3,233,547 |
| 2025-03-19 | BIOTECH GROWTH N V 10% owner | Sale | −500,000 | $2.12 | $1.1M | 2,733,547 |
| 2024-08-28 | Versant Venture Capital VI, L.P. 10% owner | Sale | −221,600 | $6.32 | $1.4M | 3,726,341 |
| 2023-06-27 | Epstein David M. SEE REMARKS | Sale 10b5-1 | −25,000 | $6.70 | $168K | 671,423 |
Page 1 of 1 · 9 trades